Balansag, Rodelia B.

HRN: 08-69-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/04/2024
07/10/2024
IV DRIP
4.5g Then 2.25g
As LD Then Q8
DM Foot
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: